Group 1 - The core viewpoint of the news highlights the recent performance and financial status of Rui Li Medical Beauty, indicating a mixed performance in the stock market and financial results [1][2]. - As of August 21, the Hang Seng Index fell by 0.24%, while Rui Li Medical Beauty's stock price increased by 11.67% to HKD 0.134 per share, with a trading volume of 2.114 million shares and a turnover of HKD 280,800 [1]. - Over the past month, Rui Li Medical Beauty has seen a cumulative increase of 5.26%, and a year-to-date increase of 12.15%, which is lower than the Hang Seng Index's increase of 25.45% [1]. Group 2 - Financial data shows that for the year ending December 31, 2024, Rui Li Medical Beauty achieved total revenue of CNY 199 million, a year-on-year increase of 5.26%, while the net profit attributable to shareholders was a loss of CNY 59.212 million, a decrease of 82.43% [1]. - The gross profit margin stands at 35.82%, and the debt-to-asset ratio is 61.78% [1]. - Currently, there are no institutional investment ratings for Rui Li Medical Beauty [1]. Group 3 - Rui Li Medical Beauty is a leading provider of medical beauty services in Zhejiang Province, China, offering a wide range of services including cosmetic surgery, minimally invasive beauty services, and skin beauty services [2]. - The company also provides medical beauty management consulting services to third-party medical beauty institutions and has begun to develop a sales network for medical beauty equipment products [2]. - As of December 31, 2021, Rui Li Medical Beauty operated four private profit-making medical beauty service institutions in China, with an average industry experience of over ten years among its more than 30 practicing physicians [2].

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示概不就因本公告全部或任何 部分內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 Raily Aesthetic Medicine International Holdings Limited 瑞麗醫美國際控股有限公司 （於開曼群島註冊成立的有限公司） 1 （股份代號：2135） 終止合約安排 茲提述招股章程及年報。 誠如招股章程及年報所披露，杭州貝麗菲爾的業務營運涉及在中國從事醫療美容 服務業務（「受限制業務」）。由於當時生效的中國適用法律法規限制外商投資於受 限制業務，本集團於2019年1月就杭州貝麗菲爾採用了合約安排，通過合約安排使 本集團得以有效控制杭州貝麗菲爾並可獲得杭州貝麗菲爾所產生的所有經濟利益。 由於杭州貝麗菲爾決定將策略重點放在醫療美容器械產品的銷售業務上並計劃申 請醫療器械經營許可證，而本公司已根據中國法律法規終止杭州貝麗菲爾的醫療 美容服務業務並註銷杭州貝麗菲爾的醫療執業許可證，因此對於受限制業務的外 資所有權限制不再適用於杭州貝麗菲爾。董事會謹此宣佈，合約安排的 ...

Company Overview - Rui Li Medical Beauty International Holdings Limited is a leading provider of medical beauty services in Zhejiang Province, China, focusing on meeting diverse customer needs in beauty and anti-aging [4] - The company offers a wide range of medical beauty services, including surgical beauty services, minimally invasive beauty services, and skin beauty services, as well as management consulting services for third-party medical beauty institutions [4] - Rui Li Medical has expanded into the sales network of medical beauty equipment, focusing on surgical implants and skincare products [4] Financial Performance - As of December 31, 2024, Rui Li Medical achieved total revenue of 199 million yuan, representing a year-on-year growth of 5.26% [2] - The company reported a net profit attributable to shareholders of -59.21 million yuan, a significant decrease of 82.43% year-on-year [2] - The gross profit margin stood at 35.82%, while the debt-to-asset ratio was 61.78% [2] Market Position and Valuation - Over the past month, Rui Li Medical has experienced a cumulative decline of 10.24%, while year-to-date, it has seen a cumulative increase of 6.54%, underperforming the Hang Seng Index's increase of 25.27% [2] - Currently, there are no institutional investment ratings for Rui Li Medical, and its price-to-earnings ratio is -0.99, ranking 101st in the industry [3] - The average price-to-earnings ratio for the healthcare equipment and services industry is -1.96, with a median of 1.36 [3]